Clinical observations nicely corroborate these aforementioned data by indicating that high SERPINB2 levels are associated with extended survival, reduced metastasis, and the inhibition of tumor growth, contrary to SERPINE1 that has been correlated with a poor prognosis and metastatic progression [51, 69, 78–81]. The gene discussed is SERPINB2; the disease is neoplasm.